Navigating Shareholder Litigation Risk in the Life Sciences Sector
Risk & Insurance - Mar 02, 2026
From clinical trial readouts to regulatory uncertainty, life science companies face unique D&O exposures at every stage of development — but disciplined practices and specialized insurance support can help mitigate the risk. The post Navigating Shareholder Litigation Risk in the Life Sciences S...
Recommended Articles
Posted: Mar 29, 2026
Misunderstanding artificial intelligence (AI) could put organizations and patients at risk. Here's w...
Posted: Mar 27, 2026
The latest people news in the industry today. The post Brian Shea Named Senior Partner of National C...
Posted: Mar 27, 2026
The latest people news in the industry today. The post Michelle Quintero Named Executive Vice Presid...